Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LYNDA E POLGREEN

Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology

NPI
1679617930
CMS profile
980792
Location
ORANGE, CA

General Payments · PY2018–2024

$193,429.07

  • Reported across 141 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$45,065.46

24 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BioMarin Pharmaceutical Inc. $45,065.46 24

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $30,837.63 33
PY2019 $47,782.13 37
PY2020 $12,557.09 7
PY2021 $25,012.07 10
PY2022 $29,529.15 22
PY2023 $2,645.54 8
PY2024 $45,065.46 24

Payment records · PY2024 (24)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
BioMarin Pharmaceutical Inc. $45.78 05/05/2024 Food and Beverage Undisputed 01/23/2026 1127060966 CMS
BioMarin Pharmaceutical Inc. $2,500.00 05/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127058041 CMS
BioMarin Pharmaceutical Inc. $193.58 08/20/2024 Travel and Lodging Undisputed 01/23/2026 1127058463 CMS
BioMarin Pharmaceutical Inc. $347.66 09/03/2024 Travel and Lodging Undisputed 01/23/2026 1127058457 CMS
BioMarin Pharmaceutical Inc. $7,318.74 09/06/2024 Travel and Lodging Undisputed 01/23/2026 1127059661 CMS
BioMarin Pharmaceutical Inc. $1,070.59 09/17/2024 Education Undisputed 01/23/2026 1127058453 CMS
BioMarin Pharmaceutical Inc. $454.51 11/15/2024 Travel and Lodging Undisputed 01/23/2026 1127058663 CMS
BioMarin Pharmaceutical Inc. $83.97 11/15/2024 Food and Beverage Undisputed 01/23/2026 1127059681 CMS
BioMarin Pharmaceutical Inc. $106.10 12/03/2024 Food and Beverage Undisputed 01/23/2026 1127058721 CMS
BioMarin Pharmaceutical Inc. $3,000.00 12/03/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1127059217 CMS
BioMarin Pharmaceutical Inc. $18.33 12/03/2024 Travel and Lodging Undisputed 01/23/2026 1127059219 CMS
BioMarin Pharmaceutical Inc. $17.39 12/03/2024 Travel and Lodging Undisputed 01/23/2026 1127059239 CMS
BioMarin Pharmaceutical Inc. $220.99 12/03/2024 Travel and Lodging Undisputed 01/23/2026 1127059241 CMS
BioMarin Pharmaceutical Inc. $16.02 12/03/2024 Travel and Lodging Undisputed 01/23/2026 1127059245 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057597 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057695 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057697 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057699 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057701 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057705 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057707 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057709 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057711 CMS
BioMarin Pharmaceutical Inc. $2,967.18 12/31/2024 Consulting Fee Undisputed 01/23/2026 1127057713 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.